Why Curaleaf Stock Was So Buzz-Worthy Today

Key Points

• Curaleaf is about to join the ranks of a closely followed index.

• This is considered to be a benchmark index on the Canadian market.

• 10 stocks we like better than Curaleaf ›

Investors were talking about -- and, crucially, buying -- shares of Curaleaf (OTC: CURLF) on the first day of the trading week. Monday saw the marijuana company's shares close more than 3% higher on news of inclusion in a prominent equity index. That rise was well higher than the 0.2% increase of the bellwether S&P 500 (SNPINDEX: ^GSPC) on the day.

Tapped for a top north-of-the-border index

Curaleaf was a topic of discussion and target for investment because it's ascending to the S&P/TSX Composite Index, considered to be the leading index for Canadian stocks (in addition to trading over the counter in the U.S., it is listed on the Toronto Stock Exchange). The move takes effect before market open on Monday, Sept. 22.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Image source: Getty Images.

The index's owner, S&P Global, makes quarterly adjustments to its indexes, and Curaleaf was included in the latest one. It was one of five companies selected for inclusion, and the only one from the broader healthcare sector.

In its own press release on the move, Curaleaf didn't hesitate to point out that this will make the company the first U.S.-headquartered pot company to be included on the S&P/TSX Composite.

A higher profile

Not only that; Curaleaf quoted CEO Boris Jordan as saying:

Being recognized among some of the most influential stocks in North America, and as the only U.S.-based cannabis operator currently in this index, validates our sector's growing legitimacy and long-term potential. Our inclusion reflects an expanded presence in public markets and broadens our access to institutional investment and index-linked vehicles as we navigate the industry's ongoing development, alongside potential regulatory catalysts.

Should you invest $1,000 in Curaleaf right now?

Before you buy stock in Curaleaf, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Curaleaf wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $670,781!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,023,752!*

Now, it’s worth noting Stock Advisor’s total average return is 1,052% — a market-crushing outperformance compared to 185% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of September 8, 2025

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends S&P Global. The Motley Fool has a disclosure policy.